**Figure 27.**

*Jane's relative values of HbA1c, BMI, and INS/d from June 2022 to December 2022. Since the beginning of treatment, HbA1c decreased from 348% of the upper limit of the acceptable value to 171%, and although insulin requirement was increasing, it was still in the reference range. Post implementation of a sensor-augmented insulin pump, MiniMed 780G, the trend of rising required insulin declined to 43% of physiological insulin needs.*

Jane expected difficulties in learning how to use the pump, however, today is satisfied with the device. Continuously on SmartGuard, current TIR: 91% (January 5, 2023).

**Current goal**: to continue the management of T1D, hypoglycemia, and ketosis.
